Associated Papers
Genetic mutations associated with congenital fibrinogen disorders: global distribution and clinical outcomes.
Nóbrega T et al.
Journal of Thrombosis and Thrombolysis, 2025
Congenital dysfibrinogenemia misdiagnosed and inappropriately treated as acute fatty liver in pregnancy: A case report and review of literature.
Jia Y et al.
World Journal of Clinical Cases, 2022
Mutations Accounting for Congenital Fibrinogen Disorders: An Update.
Richard M et al.
Seminars in Thrombosis and Hemostasis, 2022
[Analysis of two pedigrees affected with inherited dysfibrinogenemia due to a novel c.1115 T>A variant of the FGB gene].
Wang X et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2022
Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding.
Bor MV et al.
Seminars in Thrombosis and Hemostasis, 2022
Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders.
Mohsenian S et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis, 2021
Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations.
Tavasoli B et al.
International Journal of Laboratory Hematology, 2020
Mutational Epidemiology of Congenital Fibrinogen Disorders.
Casini A et al.
Thrombosis and Haemostasis, 2018
A novel fibrinogen variant in a Chinese pedigree with congenital dysfibrinogenemia caused by FGA P. Arg38Thr mutation: A case report.
Cai R et al.
Medicine, 2018
Select a paper to view details